US Map / Texas
State TX

Clinical Trials in Texas

Texas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Texas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 733 actively recruiting studies with Texas sites out of 733 registered in total. The busiest research areas in Texas are Colorectal Cancer, Ovarian Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include M.D. Anderson Cancer Center, University of Texas Southwestern Medical Center, The University of Texas Health Science Center, Houston. By stage, Texas trials break down as Phase 1 (194), Phase 2 (218), Phase 3 (133), Phase 4 (23).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
733
Recruiting Now
733
← Back to US Map
Top Conditions in Texas
Colorectal Cancer (16)Ovarian Cancer (15)Advanced Solid Tumor (15)Prostate Cancer (14)Advanced Solid Tumors (12)Solid Tumor (11)Breast Cancer (11)Cancer (10)Heart Failure (9)Acute Myeloid Leukemia (9)Schizophrenia (9)Obesity (9)

Frequently Asked Questions — Clinical Trials in Texas

How many clinical trials are currently recruiting in Texas?
ClinicalMetric currently tracks 733 actively recruiting clinical trials with at least one location in Texas. The total number of registered studies—including active but not currently enrolling trials—is 733. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Texas?
Texas hosts clinical trials across a broad range of medical conditions, including Colorectal Cancer, Ovarian Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Texas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Texas?
To join a clinical trial in Texas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Texas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Texas

NCT05955261 Phase 2
Recruiting
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric...
Condition
Acute Myeloid Leukemia
Enrollment
70 pts
Location
United States
Sponsor
St. Jude Children's Research H
View Trial →
NCT06435286 Phase 2
Recruiting
Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Can...
Condition
Suspected or Known Squamous Cell Neoplasia
Enrollment
200 pts
Location
United States, Brazil
Sponsor
Baylor College of Medicine
View Trial →
NCT07369154 Phase 3
Recruiting
52-week Open Label Safety-Tolerability Study
Condition
Schizophrenia
Enrollment
900 pts
Location
United States
Sponsor
LB Pharmaceuticals Inc.
View Trial →
NCT07609394 N/A
Recruiting
Duchenne Electronic Health Record Study
Condition
Duchenne Muscular Dystrophy (DMD)
Enrollment
2,500 pts
Location
United States
Sponsor
The Duchenne Registry
View Trial →
NCT06887205 N/A
Recruiting
Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a...
Condition
Lymphatic Reconstruction
Enrollment
20 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT05825131 N/A
Recruiting
Natural History Study of Participants With Sanfilippo Syndrome Type IIIC
Condition
Sanfilippo Syndrome Type C
Enrollment
30 pts
Location
United States, France
Sponsor
Phoenix Nest
View Trial →
NCT07075341 N/A
Recruiting
Healthy Living BEYOND Weight Study
Condition
Overweight or Obesity
Enrollment
1,000,000 pts
Location
United States
Sponsor
American Heart Association
View Trial →
NCT06351605 N/A
Recruiting
A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degener...
Condition
Dry Age-related Macular Degeneration
Enrollment
500 pts
Location
United States, Norway
Sponsor
LumiThera, Inc.
View Trial →
NCT07751068 N/A
Recruiting
Lateral Ankle Treatment
Condition
Avulsion Fracture
Enrollment
50 pts
Location
United States
Sponsor
Texas Scottish Rite Hospital f
View Trial →
NCT07265674 Phase 3
Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (P...
Condition
Advanced Biliary Tract Cancer
Enrollment
480 pts
Location
United States
Sponsor
J-Pharma Co., Ltd.
View Trial →
NCT06767514 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patie...
Condition
Non-Small Cell Lung Cancer
Enrollment
780 pts
Location
United States, Belgium, Canada
Sponsor
Summit Therapeutics
View Trial →
NCT06191549 N/A
Recruiting
Brain Stimulation Enhance Post-stroke Walking Survivors and Healthy Adults
Condition
Cerebral Vascular Accident
Enrollment
70 pts
Location
United States
Sponsor
The University of Texas Medica
View Trial →
NCT07397338 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Sol...
Condition
Advanced Solid Tumors
Enrollment
370 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
View Trial →
NCT07116967 Phase 3
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants Wit...
Condition
Plaque Psoriasis
Enrollment
3,040 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06740630 Phase 3
Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vacci...
Condition
Chickenpox
Enrollment
1,840 pts
Location
United States, Belgium, Colombia
Sponsor
GlaxoSmithKline
View Trial →
NCT05510167 N/A
Recruiting
Post-ablation Alcohol Impacts Arrhythmia Recurrence, Quality of Life and Cogniti...
Condition
Atrial Fibrillation
Enrollment
184 pts
Location
United States
Sponsor
Texas Cardiac Arrhythmia Resea
View Trial →
NCT06327100 Phase 1, Phase 2
Recruiting
Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis...
Condition
Primary Myelofibrosis
Enrollment
33 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07421700 Phase 1, Phase 2
Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With...
Condition
Urothelial Cancer
Enrollment
132 pts
Location
United States, Australia, China
Sponsor
Pfizer
View Trial →
NCT06726811 N/A
Recruiting
Droperidol and QTc Interval Changes in ED Patients
Condition
Emergency Department Patient
Enrollment
500 pts
Location
United States
Sponsor
CHRISTUS Health
View Trial →
NCT06799481 N/A
Recruiting
Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognit...
Condition
Cancer-related Cognitive Dysfunction
Enrollment
60 pts
Location
United States
Sponsor
Emory University
View Trial →
NCT07770828 Phase 3
Recruiting
Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic...
Condition
Dry Age-related Macular Degeneration
Enrollment
237 pts
Location
United States
Sponsor
Ocugen
View Trial →
NCT07196644 Phase 2
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants ...
Condition
Solid Tumors Harboring MET Amplification
Enrollment
100 pts
Location
United States, Israel, Japan
Sponsor
AbbVie
View Trial →
NCT05137119 Phase 4
Recruiting
Staphylococcus Aureus Network Adaptive Platform Trial
Condition
Staphylococcus Aureus Bacteremia
Enrollment
8,000 pts
Location
United States, Australia, Canada
Sponsor
University of Melbourne
View Trial →
NCT06602271 Phase 3
Recruiting
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
Condition
Postoperative Pain, Acute
Enrollment
320 pts
Location
United States
Sponsor
Ensysce Biosciences
View Trial →
NCT05677971 Phase 3
Recruiting
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People ...
Condition
Alpha1-Antitrypsin Deficiency
Enrollment
160 pts
Location
United States, Australia, Austria
Sponsor
Takeda
View Trial →
Page 7 of 30 — 733 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology